SCHEMBL7076576

SCHEMBL7076576

NCCCCNC(CCCCN)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 1/20 0.54
GGT1 P19440 2/20 0.53
GSR P00390 1/20 0.50
RNPEP Q9H4A4 1/20 0.48
TLR2 O60603 1/20 0.45
NOD1 Q9Y239 1/20 0.44
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44
CPB2 Q96IY4 3/20 0.44
SIRT6 Q8N6T7 1/20 0.43
SIRT1 Q96EB6 1/20 0.43
SLC6A5 Q9Y345 1/20 0.42
GNAI3 P08754 1/20 0.40
GNAO1 P09471 1/20 0.40
GNAI1 P63096 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
PAOX Q6QHF9 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL148480 1.00 FOLH1 (0.54) FOLH1GGT1GSRRNPEPTLR2
SCHEMBL31040404 0.98 FOLH1 (0.53) FOLH1GGT1GSRRNPEPTLR2
SCHEMBL28397660 0.98 FOLH1 (0.53) FOLH1GGT1GSRRNPEPTLR2
Hydrochloric Acid SCHEMBL25352316 0.96 FOLH1 (0.51) FOLH1GGT1GSRRNPEPTLR2
SCHEMBL6316197 0.96 FOLH1 (0.54) FOLH1GGT1GSRRNPEPTLR2
SCHEMBL6859366 0.96 FOLH1 (0.54) FOLH1GGT1GSRRNPEPTLR2
SCHEMBL31040389 0.94 GGT1 (0.51) FOLH1GGT1GSRRNPEPTLR2
SCHEMBL29291290 0.93 FOLH1 (0.49) FOLH1GGT1GSRRNPEPTLR2
Hydrochloric Acid SCHEMBL25353775 0.92 GGT1 (0.50) FOLH1GGT1GSRRNPEPTLR2
Hydrochloric Acid SCHEMBL25353778 0.92 GGT1 (0.50) FOLH1GGT1GSRRNPEPTLR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030233670-A1 Gene sequences and uses thereof in plants MONSANTO TECHNOLOGY LLC 2003-12-18 US disclosed
EP-1200468-A1 CRYSTALLIZATION AND STRUCTURE DETERMINATION OF i STAPHYLOCOCCUS AUREUS /i ELONGATION FACTOR P PHARMACIA & UPJOHN COMPANY (US) 2002-05-02 EP disclosed
WO-2001010906-A9 CRYSTALLIZATION AND STRUCTURE DETERMINATION OF STAPHYLOCOCCUS AUREUS ELONGATION FACTOR P UPJOHN CO (US) 2002-04-11 WO disclosed
WO-2001010906-A1 CRYSTALLIZATION AND STRUCTURE DETERMINATION OF STAPHYLOCOCCUS AUREUS ELONGATION FACTOR P PHARMACIA & UPJOHN COMPANY (US) 2001-02-15 WO disclosed
WO-1994015596-A1 COMPOSITIONS AND METHODS FOR INHIBITING DEOXYHYPUSINE SYNTHASE AND THE GROWTH OF CELLS THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1994-07-21 WO disclosed
WO-1992005190-A1 DEOXYHYPUSYL HYDROXYLASE INHIBITORS THE CHILDREN'S MEDICAL CENTER CORPORATION (US) 1992-04-02 WO disclosed